Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC) - Wikidata - wikimedia - TriplyDB

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

http://www.wikidata.org/entity/Q33335940

about

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment The role of systemic treatment before, during, and after definitive treatment CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma.Curative and organ-preserving treatment with intra-arterial carboplatin induction followed by surgery and/or radiotherapy for advanced head and neck cancer: single-center five-year results A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TI A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area.Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial.Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience.Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck Prognostic Factors of Primary Intraosseous Squamous Cell Carcinoma (PIOSCC): A Retrospective Review A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas.State-of-the-art management of locally advanced head and neck cancer.Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors.Head and neck squamous cell carcinoma: optimizing the therapeutic index.Systemic therapy strategies for head-neck carcinomas: Current status Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.Systemic therapy in head and neck cancer: changing paradigm.Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis.Intensity-modulated radiotherapy in the treatment of locoregionally advanced head and neck cancer: implementation and outcomes in a New Zealand community hospital.Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck.Docetaxel in the management of patients with head and neck squamous cell carcinoma.Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan.A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck.Induction chemotherapy of docetaxel and Cisplatin for the elderly patients with squamous cell carcinoma of the head and neck.Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion.Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx.Radiotherapy for laryngeal squamous cell carcinoma: current standards.Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer.Clinical efficacy of neoadjuvant chemotherapy with platinum-based regimen for patients with locoregionally advanced head and neck squamous cell carcinoma: an evidence-based meta-analysis.Update on role of chemotherapy in head and neck squamous cell cancer.

P2860

Q24200903-8B744F3C-2C04-47F8-AC2F-D6D2185124EA Q24235245-17FCD5FD-7F34-4560-B28C-F8B92AF50AA3 Q24242951-B4026869-E63A-42A2-ACF8-3F78F38CF585 Q26859285-0B478ABC-582D-4A40-A7F2-0E12CA3D6295 Q31040425-DF0A4697-75BC-4E13-954C-5A4D5647D5EF Q33281828-8A69DEDE-3575-4CAE-95AF-68FC27E5986D Q33491298-A3CC4649-F4E3-4610-AE45-E07E412C60AF Q34452702-6FC90B64-55C3-4E39-BF63-FFD617AB217A Q34498577-887A98F6-0644-4C2E-B1CA-656BD06CC04A Q34769944-09D81DB6-DE75-4583-B95A-8391C5C44E1C Q34991804-BCB21255-323D-482F-9341-7BFD6A84806C Q35056376-CD481085-C5C7-44FA-8B45-CA30CE7FAFC4 Q35160199-0E18D1B1-A241-4706-BEDD-3E1132D40631 Q35169306-25CC8E0F-7526-4B3B-AEC8-CC1072727079 Q35174609-A9C41801-5849-4F5B-A7D1-D29C1A53F6E0 Q35188885-21048A15-02C9-4B48-98D5-F69EB4CA567F Q35469234-39C68FB0-C9DE-4FAC-8424-6C93CB7160B9 Q35988635-3A4FEB99-3654-4265-AC23-BAFF6D875B15 Q36022400-8BF4FC71-6C43-475A-8907-59FA42EE84E3 Q36104471-866D3EE2-554F-454E-80C4-9FFB5C4CAA26 Q36104764-B8127680-827D-4A34-BC68-65642EC8041A Q36116471-41546452-66FA-4B97-A95C-D520477A3A58 Q36185629-CB62303D-3F90-4FC2-8939-FB1E7F2C7603 Q36529843-E4985244-2F15-4774-9620-46F52FBC6FC7 Q36613979-AD5DD435-6614-4DB1-85C4-C5215B6B9E67 Q36627358-9CBB0D1A-830A-478E-B50F-96DB6CEFCCBC Q36697794-84C64E81-9F5A-4B27-99E3-9BDCC2711FF1 Q37023648-AAA5DE67-3A4F-44D8-B13C-6AD2414D3FB0 Q37093034-590D915D-A69F-46B0-A65B-503F00BD89D6 Q37202758-9E4E637F-881A-4D94-96BB-E8FFB1122789 Q37206229-92BCB964-2028-4750-ABC7-122A935E95B3 Q37322374-5E414C11-AF99-4D72-972F-539EE0E2F765 Q37336466-80376E25-0EBA-41D7-A726-80852B3B03F7 Q37338154-4AAAFAEF-B902-45F2-9811-2F658524B444 Q37342399-CF9346FA-8BF5-48F5-9712-0D71E67D4560 Q37364496-7569BD89-91CE-489B-9B1E-D5417E15BEF8 Q37788244-2E5D8035-C5F0-4E73-AF9B-3E029A6251AB Q37799933-06AA7A42-000E-4B49-8B3C-2C14FD3697E7 Q37930854-E7D1CEE1-D459-45DC-BD13-CE5CB932D621 Q38038836-52BDC16C-276E-4C49-80F1-9A2A226DB346

P2860

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

http://www.wikidata.org/entity/Q33335940

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Randomized trial of neoadjuvan ...... de la Tête et du Cou (GETTEC)

@ast

Randomized trial of neoadjuvan ...... de la Tête et du Cou (GETTEC)

@en

Randomized trial of neoadjuvan ...... s Tumeurs de la Tête et du Cou

@nl

type

label

Randomized trial of neoadjuvan ...... de la Tête et du Cou (GETTEC)

@ast

Randomized trial of neoadjuvan ...... de la Tête et du Cou (GETTEC)

@en

Randomized trial of neoadjuvan ...... s Tumeurs de la Tête et du Cou

@nl

prefLabel

Randomized trial of neoadjuvan ...... de la Tête et du Cou (GETTEC)

@ast

Randomized trial of neoadjuvan ...... de la Tête et du Cou (GETTEC)

@en

Randomized trial of neoadjuvan ...... s Tumeurs de la Tête et du Cou

@nl

P1433

Q33335940-3E9B6F9D-4CB6-4011-88F5-150C081D8400

P1476

Q33335940-1C280A40-A9E3-4DD3-B3B7-823DAEBC93FA

P2093

Q33335940-1DF0BA9B-87CB-4A8D-A988-4F5DA6C27009

Q33335940-2012F704-46B2-495A-92C0-0EF0B2C81E1A

Q33335940-2C4B7DF6-DE2D-4B28-A73C-0CD56BBE7346

Q33335940-364B82DC-4C95-4A22-890A-A12CA25924AF

Q33335940-505A8287-D997-4734-9851-F5B1F4714509

Q33335940-5AD693E5-2E61-4E6B-A16D-FF17577A981C

Q33335940-ACA90BA5-C3F8-4B76-A137-67C755A547DC

Q33335940-B05673CF-9464-4AAB-A8DE-795314D640F3

Q33335940-CB7B7900-45E4-4324-B0E0-B633A82D4F96

Q33335940-E3D87FCA-FEEF-4EE7-972C-BDCAFD883EE1

P2860

Q33335940-B43A9965-99D9-4069-B975-18A880B5AF20

Q33335940-ECE4BF38-058F-4FAD-8A34-F1769CD806C2

P2888

Q33335940-2BF1609D-8BA1-4F46-AA78-6F3E7F627D41

P304

Q33335940-FA636373-A0DD-4E9C-B89E-3F520421EFE2

P31

Q33335940-63BDD4A9-F89E-4400-85FC-113D0069429C

P356

Q33335940-9910B7D7-A6F3-4C70-B030-16B1C94E78A6

P407

Q33335940-7B3F3B0F-997B-44BC-9440-8EF8943DE1AF

P433

Q33335940-43F0FD0F-ED78-40CC-A35D-902A5A905B4F

P478

Q33335940-3CFDB879-0FE1-43D0-9BD1-7A5372ADDD1B

P577

Q33335940-41664F5D-0835-482C-9A5B-E77F5EBA9C16

P5875

Q33335940-69CC4BDC-F206-4E0C-8BD1-8154AC7EB970

P6179

Q33335940-603BB68E-086F-4E7B-A3BE-E3D04F3C1226

P698

Q33335940-D9E02936-D341-489E-A3F6-BC43EA2672D3

P921

Q33335940-BB3CC6D9-20E6-4BE4-AF1E-7AB4BD445555

P932

Q33335940-CCF11269-7A9E-4739-9200-8D6643A5AD1B

P356

P1433

British Journal of Cancer

P1476

Randomized trial of neoadjuvan ...... de la Tête et du Cou (GETTEC)

@en

P2093

B Coche-Dequeant

http://www.w3.org/2001/XMLSchema#string

B Luboinski

http://www.w3.org/2001/XMLSchema#string

B Rhein

http://www.w3.org/2001/XMLSchema#string

C Domenge

http://www.w3.org/2001/XMLSchema#string

C Hill

http://www.w3.org/2001/XMLSchema#string

D De Raucourt

http://www.w3.org/2001/XMLSchema#string

French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

http://www.w3.org/2001/XMLSchema#string

H Sancho-Garnier

http://www.w3.org/2001/XMLSchema#string

J L Lefebvre

http://www.w3.org/2001/XMLSchema#string

M Stromboni-Luboinski

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.

P2888

P304

1594-1598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2000.1512

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12142152

http://www.w3.org/2001/XMLSchema#string

P6179

1029212131

http://www.w3.org/2001/XMLSchema#string

P698

11189100

http://www.w3.org/2001/XMLSchema#string

P921

P932

2363468

http://www.w3.org/2001/XMLSchema#string